首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   58831篇
  免费   6151篇
  国内免费   1692篇
耳鼻咽喉   522篇
儿科学   1017篇
妇产科学   316篇
基础医学   6630篇
口腔科学   1151篇
临床医学   7895篇
内科学   14758篇
皮肤病学   857篇
神经病学   3590篇
特种医学   1026篇
外国民族医学   1篇
外科学   5179篇
综合类   8664篇
现状与发展   15篇
一般理论   4篇
预防医学   2998篇
眼科学   522篇
药学   5453篇
  39篇
中国医学   4475篇
肿瘤学   1562篇
  2024年   83篇
  2023年   1200篇
  2022年   1209篇
  2021年   2548篇
  2020年   2575篇
  2019年   2453篇
  2018年   2260篇
  2017年   2483篇
  2016年   2629篇
  2015年   2710篇
  2014年   4045篇
  2013年   4725篇
  2012年   3464篇
  2011年   3779篇
  2010年   2960篇
  2009年   2715篇
  2008年   2597篇
  2007年   2691篇
  2006年   2394篇
  2005年   2101篇
  2004年   1719篇
  2003年   1547篇
  2002年   1319篇
  2001年   1186篇
  2000年   991篇
  1999年   785篇
  1998年   645篇
  1997年   653篇
  1996年   591篇
  1995年   685篇
  1994年   579篇
  1993年   514篇
  1992年   428篇
  1991年   383篇
  1990年   338篇
  1989年   302篇
  1988年   248篇
  1987年   233篇
  1986年   227篇
  1985年   335篇
  1984年   248篇
  1983年   195篇
  1982年   227篇
  1981年   219篇
  1980年   134篇
  1979年   79篇
  1978年   68篇
  1977年   56篇
  1976年   46篇
  1973年   17篇
排序方式: 共有10000条查询结果,搜索用时 19 毫秒
91.
92.
93.
Felbamate is an anticonvulsant used in the treatment of epilepsy. In this study, we investigated the antidepressant‐like actions of felbamate in mice. The effects of felbamate were first assessed using the forced swimming test (FST) and tail suspension test (TST), and then investigated in the chronic unpredictable mild stress (CUMS) and chronic social defeat stress (CSDS) models of depression. The changes in the hippocampal brain‐derived neurotrophic factor (BDNF) signaling cascade after chronic stress and felbamate treatment were also examined. It was found that felbamate exhibited antidepressant‐like activities in the FST and TST without affecting the locomotor activity of mice. Felbamate was also effective in both the CUMS and CSDS models of depression. Moreover, felbamate administration fully restored the decreased hippocampal BDNF signaling pathway in both the CUMS‐stressed and CSDS‐stressed mice. Collectively, felbamate has antidepressant‐like actions in mice involving the hippocampal BDNF system.  相似文献   
94.
95.
PurposeTo evaluate the safety and efficacy of balloon pulmonary angioplasty (BPA) for nonoperable chronic thromboembolic pulmonary hypertension (CTEPH) patients during the initial experience of a single center.MethodsA total of 18 CTEPH patients (5 with residual pulmonary hypertension after pulmonary endarterectomy) were treated with BPA during the period 2014–2018 and were retrospectively reviewed. Mean age was 61 ± 19 years; 55% were female; mean pulmonary artery pressure was 44 ± 12 mmHg; cardiac output was 4.3 ± 1.0 l/min; and pulmonary vascular resistance was 8.4 ± 3.6 WU. Patients were evaluated by New York Heart Association functional class, 6-minute walk distance, N-terminal pro b-type natriuretic peptide, echocardiography, right heart catheterization, and before and after completions of BPA.ResultsA total of 91 procedures were performed, with a median number of 4 BPA sessions per patient (range, 2–8). There were no deaths or major complications requiring extracorporeal support or (non)invasive ventilation. The most common complication was self-limiting hemoptysis (3%). According to Society of Interventional Radiology classification, 4 mild, 4 moderate, and 1 severe adverse events were noted. Invasive hemodynamics significantly improved, with a cardiac index increase of 15% (P = .0333), decrease of mean pulmonary artery pressure of 30% (P = .0013), and decrease of pulmonary vascular resistance of 45% (P = .0048). Stroke volume index (P = .0171) and pulmonary arterial compliance (P = .0004) were also significantly enhanced.ConclusionsBPA significantly improves cardiopulmonary hemodynamics with an acceptable safety profile. Further studies assessing the long-term efficacy of BPA are required.  相似文献   
96.
Erosive pustular dermatosis of the scalp (EPDS) is an uncommon chronic inflammatory response to scalp trauma that usually resolves with cicatricial alopecia. It most commonly affects elderly patients with a history of actinic damage. Herein, we describe a 16‐year‐old girl with acrofacial dysostosis type 1 presenting after surgery with crusting purulent scalp lesions, whose clinical presentation and histopathologic findings were consistent with EPDS. A review of the literature on EPDS in children is also detailed.  相似文献   
97.
Periosteal new bone formation (PNBF) is a common finding in a large spectrum of diseases. In clinical practice, the morphology and location of periosteal lesions are frequently used to assist in the differential diagnosis of distinct bone conditions. Less commonly reported is the presence of PNBF on the ribs. This contrasts with the data retrieved from the study of skeletonized human remains that shows a high frequency of cases and a strong, albeit not specific, association between periosteal rib lesions and pulmonary conditions (e.g. tuberculosis). Despite that, an overall disagreement regarding the specificity and non‐specificity of periosteal reactions exists in the study of dry bone remains. The insufficient number of clinical models exploring the morphology and the pathophysiology of PNBF's and the lack of systematic studies of pathological samples with a known diagnosis are claimed as major reasons for the disagreements. This study aimed to describe and compare the macroscopic and the histomorphologic appearance of periosteal rib lesions and to discuss their usefulness as diagnostic indicators. To pursue this goal, an assemblage of 13 rib samples (males = 11, females = 2, mean age‐at‐death = 36.6 years old) was collected from the Luis Lopes Skeletal Collection (Museu Nacional de História Natural e da Ciência, Universidade de Lisboa, Portugal). The assemblage belongs to individuals who died from pulmonary‐TB (group 1), non‐TB pulmonary infections (group 2) and other conditions (group 3). Prior to sample preparation, the ribs were visually inspected and the PNBF described according to its thickness, the degree of cortical integration and the type of new bone formed (e.g. woven, lamellar or both). After sampling, each bone sample was prepared for histological analysis under plane and polarized light microscopy. Macroscopically, the results showed no differences in the new bone composition between cause‐of‐death groups. Only slight differences in the degree of cortical integration, which was most frequently classified as mild to high in the pulmonary‐TB group, were observed. Histologically, no distinguishing features were identified by pathological group. However, new bone microarchitectures were observed compatible with (1) acute, fast‐growing processes (e.g. spiculated reactions), (2) long‐standing processes with a rapid bone formation (e.g. appositional layering of bone) and/or (3) chronic, slow‐growing processes (e.g. layers of compact lamellae). To some extent, these distinct rates of disease progression resonate with the cause‐of‐death listed for some individuals. Despite the small sample size, the results of this investigation are in agreement with previous studies, according to which the macroscopic and histological appearance of periosteal formations are not specific for a particular pathological conditions. Nevertheless, the results support the conclusion that the morphology of periosteal lesions is a good biological indicator for inferring the rate of progression and duration of pathological processes. This study provides important reference data regarding the histomorphology of periosteal lesions that can be used for comparative purposes, as well as to narrow down the differential diagnosis in unidentified skeletal remains.  相似文献   
98.
99.
100.
目的:探索芪参补气胶囊治疗稳定期慢性阻塞性肺疾病(COPD)肺气虚证的临床疗效与安全性。方法:选取2017年10月16日至2018年11月20日在新疆维吾尔族自治区克州人民医院呼吸内科门诊随诊的COPD稳定期肺气虚证患者480例作为研究对象,随机分为观察组和对照组,每组240例,进行为期52周的观察。2组患者均给予健康指导、家庭氧疗、沙美特罗替卡松粉吸入剂、竹沥胶囊等基础治疗;对照组在基础治疗上给予玉屏风胶囊口服,2粒/次,3次/d;观察组在基础治疗上给予芪参补气胶囊口服,3粒/次,3次/d。观察比较2组患者的相关指标。结果:观察组平均急性加重次数(1.62±0.93)次,对照组(1.83±0.97)次,观察组发作次数显著减少(t=2.262,P=0.012)。观察组相对于对照组的急性加重风险RR=0.869(0.763~0.988,P=0.032),降低了13.1%。伴有咳嗽、喘息、便秘或吸烟的患者,观察组急性加重风险更低(P<0.05)。观察组CAT评分、FEV1显著优于对照组(P<0.05)。观察组炎性反应指标(TNF-α、IL-6、IL-8)改善情况显著优于对照组。观察组不良事件发生率显著低于对照组。结论:芪参补气胶囊与玉屏风散均具有良好的提高免疫功能,改善COPD属肺气虚证者咳痰喘症状的作用。其中芪参补气胶囊减少急性加重风险的效果较玉屏风胶囊更好,且安全性良好,值得推广使用。  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号